JUN 10, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Valacyclovir (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for valacyclovir tablets; does not report clinical trial outcomes or comparative efficacy data.
Reported
Approval date2026-06-10
Product strengths500 mg and 1 g base equivalents